Nanotechnology Now - Press Release: Endomagnetics Expands its Horizons

Home > Press > Endomagnetics Expands its Horizons

Abstract:
Cambridge company Endomagnetics is receiving enquiries from across the world after it featured on the BBC World Horizons programme recently. The Horizons series features companies and technologies that have the potential to address some of the planet's most pressing challenges. In Endomagnetics' case, they have developed a medical device called SentiMag® based on principles of nano-magnetism, which gives clinicians a much simpler and cheaper method for tracking the spread of cancers, especially breast cancer.

Endomagnetics Expands its Horizons

Cambridge, UK | Posted on April 18th, 2012

As CEO Dr Eric Mayes explained in the video clip, by avoiding the need for radioactive isotopes, the availability of a key technique - sentinel lymph node biopsy - is significantly extended. In some parts of the world, only 5% of the patients who could benefit have access to this technique.

BBC reporter Adam Shaw visited the team in Cambridge as well as filming at Guy's Hospital, London, where he saw a demonstration of how the SentiMag® instrument is used in an operating theatre. Shaw was enthusiastic about nanotechnology and commented: "This could be one technology that's on the wave of what some experts have dubbed the ‘next industrial revolution'".

####

About Endomagnetics
Endomagnetics was founded to solve cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology. Endomagnetics is developing a portfolio of medical device products based on a patented ability to detect magnetic materials in the human body with exceptional sensitivity. The technology was originally developed at University College London and the University of Houston.

The company’s first product, the SentiMag®, is an ultrasensitive hand-held probe for tracking injected Sienna+™ nanoscale magnetic materials in the human body. Cambridge, UK-based Endomagnetics is in the process of delivering its technology to global markets. For more information please visit www.endomagnetics.com.

For more information, please click here

Contacts:
Editorial contact:
Terry Nicklin
KeynotePR Ltd
Tel: +44 (0)7923 540695

Company contact:
Dr Eric Mayes
CEO
Endomagnetics Ltd
Tel: +44 (0)1223 437131

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: